A new study suggests once developed, having a universal vaccine in advance of the next…
Advancements in the study of two rare heart conditions—peripartum cardiomyopathy (PPCM), and dilated cardiomyopathy (DCM)—contributed…
Environmental epidemiologists at Columbia University Mailman School of Public Health, in collaboration with an interdisciplinary…
The U.S. health care response during the early stages of the COVID-19 pandemic unveiled challenges…
Black people consistently had a higher rate of stroke than white people over a recent…
A sex-specific panel of 10 proteins can pick up 18 different early stage cancers, representing…
Novel findings from a preclinical head-to-head comparison show that administering a COVID-19 vaccine as a…
Adults with posttraumatic stress disorder (PTSD) have smaller cerebellums, according to new research from a…
Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical…
AbbVie Launches PRODUODOPA for People Living with Advanced Parkinson’s Disease in the European Union
– PRODUODOPA (foslevodopa/foscarbidopa) is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment…
